Home / Stocks / DAVE

Dave (DAVE, Consumer lending & cards) Stock Valuation & Fair Value

Mixed on our tests

Dave (DAVE, Consumer lending & cards) trades at a current P/E of 21.0, about 13% above its historical normal valuation, with a forward growth estimate of 39.6% and a PEG of 0.53. Priced at its historical normal P/E of 18.6 on the same blended earnings, the 2026-11-06 close of $278.59 corresponds to about $246 a share. This is a valuation reference, not a price target.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

DATA AS OF 2026-11-07
Current P/E
21.0
Normal P/E
18.6
PEG
0.53
Fwd growth
39.6%
Div yield
0.0%
RSI (14)
35.3
Neutral
Technical context
  • Price $278.59 at the Nov 6 close, 18.1% below the 20-day average ($340.33) and 19.9% below the 50-day ($347.96).
  • RSI (14) at 35.3.
  • 52-week range $155.92 to $442.53: the price is 37.0% below the high and 78.7% above the low.

The Street vs SeerForecast

Wall Street's mean price target for DAVE is $445.07 across 14 analysts, 59.8% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from strong on our tests (2026-07-31) to trading above its usual valuation (2026-11-02). New rating rules took effect in the week of 2026-10-12, and this rating moved across that change, so part of the move may come from the new rules rather than the company.

Current P/E and rating by weekCurrent P/E moved from 25.6 to 23.9 between 2026-07-31 and 2026-10-30, against a normal P/E of 18.6, with 4 rating changes over 14 recorded weeks.2026-07-31: P/E 25.6, Strong on our tests, recalculated for the week of 2026-07-312026-07-31: P/E 25.3, Strong on our tests, recorded live 2026-08-032026-08-07: P/E 25.3, Strong on our tests, recalculated for the week of 2026-08-072026-08-07: P/E 22.6, Strong on our tests, recorded live 2026-08-102026-08-14: P/E 22.6, Strong on our tests, recalculated for the week of 2026-08-142026-08-14: P/E 24.8, Strong on our tests, recorded live 2026-08-172026-08-21: P/E 24.8, Strong on our tests, recalculated for the week of 2026-08-212026-08-21: P/E 26.5, Significantly overvalued, recorded live 2026-08-242026-08-27: P/E 26.5, Significantly overvalued, recalculated for the week of 2026-08-272026-08-28: P/E 26.5, Significantly overvalued, recalculated for the week of 2026-08-282026-08-28: P/E 26.5, Significantly overvalued, recalculated for the week of 2026-08-302026-08-28: P/E 28.3, Significantly overvalued, recorded live 2026-08-312026-09-04: P/E 28.3, Significantly overvalued, recalculated for the week of 2026-09-052026-09-04: P/E 28.5, Significantly overvalued, recorded live 2026-09-072026-09-11: P/E 28.5, Significantly overvalued, recalculated for the week of 2026-09-122026-09-11: P/E 26.2, Significantly overvalued, recorded live 2026-09-142026-09-18: P/E 26.2, Significantly overvalued, recalculated for the week of 2026-09-192026-09-18: P/E 25.3, Trading above its usual valuation, recorded live 2026-09-212026-09-25: P/E 25.3, Trading above its usual valuation, recalculated for the week of 2026-09-262026-09-25: P/E 24.4, Trading above its usual valuation, recorded live 2026-09-282026-10-02: P/E 24.4, Trading above its usual valuation, recalculated for the week of 2026-10-032026-10-02: P/E 25.9, Trading above its usual valuation, recorded live 2026-10-052026-10-09: P/E 25.9, Trading above its usual valuation, recalculated for the week of 2026-10-102026-10-09: P/E 27.5, Significantly overvalued, recorded live 2026-10-122026-10-16: P/E 27.5, Significantly overvalued, recalculated for the week of 2026-10-172026-10-16: P/E 27.5, Significantly overvalued, recorded live 2026-10-192026-10-23: P/E 26.5, Significantly overvalued, recorded live 2026-10-262026-10-30: P/E 26.5, Significantly overvalued, recalculated for the week of 2026-10-312026-10-30: P/E 23.9, Trading above its usual valuation, recorded live 2026-11-0220.022.525.027.5Jul 31Aug 23Sep 15Oct 7Oct 30Normal P/E 18.6
Strong on our testsTrading above its usual valuationSignificantly overvaluedLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-07-31P/E 25.6+38%Strong on our tests (recalculated)
2026-08-10P/E 22.6+22%Strong on our tests
2026-08-24P/E 26.5+43%Significantly overvalued
2026-09-07P/E 28.5+53%Significantly overvalued
2026-09-21P/E 25.3+37%Trading above its usual valuation
2026-10-12P/E 27.5+48%Significantly overvalued (across a rating rules change)
2026-11-02P/E 23.9+29%Trading above its usual valuation ← now
Show all 29 readings
WeekCurrent P/EPremium to normal P/ERating
2026-07-31P/E 25.6+38%Strong on our tests (recalculated)
2026-08-03P/E 25.3+36%Strong on our tests
2026-08-07P/E 25.3+36%Strong on our tests (recalculated)
2026-08-10P/E 22.6+22%Strong on our tests
2026-08-14P/E 22.6+22%Strong on our tests (recalculated)
2026-08-17P/E 24.8+34%Strong on our tests
2026-08-21P/E 24.8+34%Strong on our tests (recalculated)
2026-08-24P/E 26.5+43%Significantly overvalued
2026-08-27P/E 26.5+43%Significantly overvalued (recalculated)
2026-08-28P/E 26.5+43%Significantly overvalued (recalculated)
2026-08-30P/E 26.5+43%Significantly overvalued (recalculated)
2026-08-31P/E 28.3+53%Significantly overvalued
2026-09-05P/E 28.3+53%Significantly overvalued (recalculated)
2026-09-07P/E 28.5+53%Significantly overvalued
2026-09-12P/E 28.5+53%Significantly overvalued (recalculated)
2026-09-14P/E 26.2+41%Significantly overvalued
2026-09-19P/E 26.2+41%Significantly overvalued (recalculated)
2026-09-21P/E 25.3+37%Trading above its usual valuation
2026-09-26P/E 25.3+37%Trading above its usual valuation (recalculated)
2026-09-28P/E 24.4+31%Trading above its usual valuation
2026-10-03P/E 24.4+31%Trading above its usual valuation (recalculated)
2026-10-05P/E 25.9+40%Trading above its usual valuation
2026-10-10P/E 25.9+40%Trading above its usual valuation (recalculated)
2026-10-12P/E 27.5+48%Significantly overvalued (across a rating rules change)
2026-10-17P/E 27.5+48%Significantly overvalued (recalculated)
2026-10-19P/E 27.5+48%Significantly overvalued
2026-10-26P/E 26.5+43%Significantly overvalued
2026-10-31P/E 26.5+43%Significantly overvalued (recalculated)
2026-11-02P/E 23.9+29%Trading above its usual valuation ← now

Frequently asked questions

Is Dave stock overvalued?

At a current P/E of 21.0 versus its historical normal P/E of 18.6, Dave trades about 13% above its typical valuation, with a PEG of 0.53 on 39.6% forward growth. tickerseer currently rates it mixed on our tests.

What is Dave's fair value and PEG?

Dave trades at a current P/E of 21.0 against a historical normal P/E of 18.6, a PEG of 0.53, and a forward growth estimate of 39.6%. Priced at its historical normal P/E of 18.6 on the same blended earnings, the 2026-11-06 close of $278.59 corresponds to about $246 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Dave changed?

tickerseer's rating moved from strong on our tests (2026-07-31) to trading above its usual valuation (2026-11-02). New rating rules took effect in the week of 2026-10-12, and this rating moved across that change, so part of the move may come from the new rules rather than the company.

What is the analyst price target for Dave?

The mean Wall Street price target for Dave is $445.07 across 14 analysts, 59.8% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Consumer lending & cards. Create a free account to see the full analysis: the SeerAI score, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track DAVE free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.